Upperton Pharma Solutions is a leading UK-based contract development and manufacturing organisation (CDMO) specialising in formulation development, clinical trial manufacturing and manufacturing services for a wide range of dosage forms, including oral solids, liquids, semi-solids, inhalation and parenteral products.
With a 60,000 sq. ft state-of-the-art facility and a team of experienced scientists, Upperton offers tailored solutions to accelerate drug development from pre-clinical to market. Upperton are committed to innovation, quality, and share in our customers’ dedication to changing the lives of patients.
Upperton collaborates closely with global pharmaceutical and biotech companies to bring novel therapies to market efficiently and effectively.